218 related articles for article (PubMed ID: 28235541)
21. Polo-like kinase 1 expression is a prognostic factor in human colon cancer.
Weichert W; Kristiansen G; Schmidt M; Gekeler V; Noske A; Niesporek S; Dietel M; Denkert C
World J Gastroenterol; 2005 Sep; 11(36):5644-50. PubMed ID: 16237758
[TBL] [Abstract][Full Text] [Related]
22. PLK1-dependent activation of LRRK1 regulates spindle orientation by phosphorylating CDK5RAP2.
Hanafusa H; Kedashiro S; Tezuka M; Funatsu M; Usami S; Toyoshima F; Matsumoto K
Nat Cell Biol; 2015 Aug; 17(8):1024-35. PubMed ID: 26192437
[TBL] [Abstract][Full Text] [Related]
23. Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcoma.
Stehle A; Hugle M; Fulda S
Cancer Lett; 2015 Aug; 365(1):37-46. PubMed ID: 25917079
[TBL] [Abstract][Full Text] [Related]
24. Low-dose arsenic-mediated metabolic shift is associated with activation of Polo-like kinase 1 (Plk1).
Li Z; Lu Y; Ahmad N; Strebhardt K; Liu X
Cell Cycle; 2015; 14(19):3030-9. PubMed ID: 26292025
[TBL] [Abstract][Full Text] [Related]
25. Polo-like kinase 1 is a potential therapeutic target in human melanoma.
Jalili A; Moser A; Pashenkov M; Wagner C; Pathria G; Borgdorff V; Gschaider M; Stingl G; Ramaswamy S; Wagner SN
J Invest Dermatol; 2011 Sep; 131(9):1886-95. PubMed ID: 21654832
[TBL] [Abstract][Full Text] [Related]
26. Tumor inhibition by genomically integrated inducible RNAi-cassettes.
Kappel S; Matthess Y; Zimmer B; Kaufmann M; Strebhardt K
Nucleic Acids Res; 2006; 34(16):4527-36. PubMed ID: 16945954
[TBL] [Abstract][Full Text] [Related]
27. Hsa-let-7b inhibits cell proliferation by targeting PLK1 in HCC.
He Z; Deng W; Jiang B; Liu S; Tang M; Liu Y; Zhang J
Gene; 2018 Oct; 673():46-55. PubMed ID: 29913237
[TBL] [Abstract][Full Text] [Related]
28. Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells.
Han DP; Zhu QL; Cui JT; Wang PX; Qu S; Cao QF; Zong YP; Feng B; Zheng MH; Lu AG
Med Sci Monit; 2012 Jun; 18(6):BR237-46. PubMed ID: 22648245
[TBL] [Abstract][Full Text] [Related]
29. Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells.
Francescangeli F; Patrizii M; Signore M; Federici G; Di Franco S; Pagliuca A; Baiocchi M; Biffoni M; Ricci Vitiani L; Todaro M; De Maria R; Zeuner A
Stem Cells; 2012 Sep; 30(9):1819-30. PubMed ID: 22753241
[TBL] [Abstract][Full Text] [Related]
30. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Plk1 induces mitotic infidelity and embryonic growth defects in developing zebrafish embryos.
Jeong K; Jeong JY; Lee HO; Choi E; Lee H
Dev Biol; 2010 Sep; 345(1):34-48. PubMed ID: 20553902
[TBL] [Abstract][Full Text] [Related]
32. Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway.
Ma X; Wang L; Huang D; Li Y; Yang D; Li T; Li F; Sun L; Wei H; He K; Yu F; Zhao D; Hu L; Xing S; Liu Z; Li K; Guo J; Yang Z; Pan X; Li A; Shi Y; Wang J; Gao P; Zhang H
Nat Commun; 2017 Nov; 8(1):1506. PubMed ID: 29138396
[TBL] [Abstract][Full Text] [Related]
33. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
34. Involvement of Polo-like kinase 1 (Plk1) in quiescence regulation of cancer stem-like cells of the gastric cancer cell lines.
Zhu L; Xing S; Zhang L; Yu JM; Lin C; Yang WJ
Oncotarget; 2017 Jun; 8(23):37633-37645. PubMed ID: 28430578
[TBL] [Abstract][Full Text] [Related]
35. Polo-like kinase1 (Plk1) knockdown enhances cisplatin chemosensitivity via up-regulation of p73α in p53 mutant human epidermoid squamous carcinoma cells.
Tyagi S; Bhui K; Singh R; Singh M; Raisuddin S; Shukla Y
Biochem Pharmacol; 2010 Nov; 80(9):1326-34. PubMed ID: 20655883
[TBL] [Abstract][Full Text] [Related]
36. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
Zhou Q; Bai M; Su Y
Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
38. Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation.
Shirakawa J; Fernandez M; Takatani T; El Ouaamari A; Jungtrakoon P; Okawa ER; Zhang W; Yi P; Doria A; Kulkarni RN
Cell Metab; 2017 Apr; 25(4):868-882.e5. PubMed ID: 28286049
[TBL] [Abstract][Full Text] [Related]
39. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
[TBL] [Abstract][Full Text] [Related]
40. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
Ito T; Sato F; Kan T; Cheng Y; David S; Agarwal R; Paun BC; Jin Z; Olaru AV; Hamilton JP; Selaru FM; Yang J; Matsumura N; Shimizu K; Abraham JM; Shimada Y; Mori Y; Meltzer SJ
Int J Cancer; 2011 Nov; 129(9):2134-46. PubMed ID: 21170987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
